Menu

NL
EN

Does your organisation operate in a regulated market, such as healthcare, energy and water networks or culture? And do you consider sharpening your strategy? SiRM can offer you valuable assistance

News

News 11 January 2021

SiRM, L.E.K. Consulting and RAND Europe win tender for study into the financial ecosystem of medicine development

News 3 January 2020

Dutch Authority for Consumers and Markets will further clarify guideline “Collective procurement of prescription drugs” based on SiRM evaluation

News 9 July 2019

SiRM en Finance Ideas report on pros and cons of for-profit health care providers sent to House of Representatives

News 4 July 2019

Minister adopts SiRM's recommendations on improvement of expensive medicines policy

“SiRM works for all parties in the market. This is only possible if your analyses are independent.”

Jan-Peter Heida View profile

SiRM contributes to aligning regulated markets with the needs and wishes of citizens

Publication 2 January 2020

Clarification of competition rules is helpful, but not a panacea for lower prices of prescription drugs

By Saskia van der Erf

Competition regulation

Pharmaceutical care

Publication 4 July 2019

Up for high-hanging fruit – Evaluation of the Dutch expensive medicines policy 2016-2018

By Saskia van der Erf

Healthcare purchasing

Pharmaceutical care

View all publications

Contact

dr. Jan-Peter Heida (partner)
+31 6 41 36 23 59 jp.heida@sirm.nl

Pam van der Meer (officemanager)
+31 6 21 32 55 55 pam.vandermeer@sirm.nl

SiRM

Stadsplateau 17
3521 AZ Utrecht
The Netherlands

info@sirm.nl
Google maps

CoC SiRM Group B.V.: 67397395
CoC SiRM Healthcare B.V.: 67401600